Sequence of treatment matters in second-line and third-line therapy for a certain type of blood cancer
Sequence of treatment matters in second-line and third-line therapy for a certain type of blood cancer
Permanent gene editing of T cell DNA shown to be safe in first clinical trial
New gene-editing therapy shows early success in fighting advanced GI cancers. Illustration provided by University of Minnesota
Engineered T cells targeting solid tumors show promising results in early patient trial
The IMA203 treatment uses T cells engineered to target the PRAME peptide, which is almost exclusively produced by solid tumors and not...
Cancer immunotherapy can extend survival even if stopped due to side effects
Study author Federica Pecci, MD of Dana Farber Cancer Institute – photo credit Dana Farber CANCER DIGEST – April 20, 2025 – Cancer...
Opdivo approved for subtype of colorectal cancer
From 5% to 15% of people colorectal cancer have the MSI-H subtype CANCER DIGEST – April 12, 2025 – The FDA this week approved another...
Some women with triple negative early stage breast cancer may be able to safely forgo surgery
Some women with triple negative early stage breast cancer may be able to safely forgo surgery
